Coumadin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials
• Forums

Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis
Condition:   Atopic Dermatitis Interventions:   Dietary Supplement: Caffeine;   Drug: Metoprolol;   Drug: Midazolam;   Drug: Warfarin;   Dietary Supplement: Vitamin K;   Drug: Omeprazole;   Drug: Rocatinlimab Sponsor:   Amgen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 6, 2023 Category: Research Source Type: clinical trials